Volume 71, Issue 10, Pages (May 2007)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 1, Pages (July 2004)
Advertisements

Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
From Delivery to Dialysis: Does Preeclampsia Count?
Mesenchymal Stem Cells Ameliorate Podocyte Injury and Proteinuria in a Type 1 Diabetic Nephropathy Rat Model  Shuai Wang, Yi Li, Jinghong Zhao, Jingbo.
Acute kidney injury following proton pump inhibitor therapy
Renal manifestations in Fabry disease and therapeutic options
Volume 68, Issue 6, Pages (December 2005)
The Case | Diabetic nephropathy in a nondiabetic smoker?
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
K.M. Schumacher, S.C. Phua, A. Schumacher, J.Y. Ying 
Carbon monoxide reduces pulmonary ischemia–reperfusion injury in miniature swine  Hisashi Sahara, MD, Akira Shimizu, MD, PhD, Kentaro Setoyama, DVM, PhD,
Preeclampsia: A renal perspective
Respiratory syncytial virus nephropathy in rats
Volume 79, Issue 3, Pages (February 2011)
Volume 85, Issue 2, Pages (January 2014)
Volume 75, Issue 10, Pages (May 2009)
Volume 56, Issue 6, Pages (December 1999)
Volume 57, Issue 2, Pages (October 2000)
Quiz Page July 2007 American Journal of Kidney Diseases
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
A new mouse model of immune-mediated podocyte injury
Volume 73, Issue 4, Pages (February 2008)
Volume 70, Issue 8, Pages (October 2006)
Volume 59, Issue 3, Pages (March 2001)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Proinflammatory effects of iron sucrose in chronic kidney disease
Oliver Vonend, Clare M. Turner  Kidney International 
Non–hepatitis virus associated mixed essential cryoglobulinemia
Volume 70, Issue 3, Pages (August 2006)
Volume 54, Issue 2, Pages (August 1998)
Nephrotic syndrome associated with hemophagocytic syndrome
Helen Liapis, Albert K. Ho, Diane Brown, Graeme Mindel, Gerald Gleich 
Volume 79, Issue 6, Pages (March 2011)
A Case of “Pure” Preeclampsia With Nephrotic Syndrome Before 15 Weeks of Gestation in a Patient Whose Renal Biopsy Showed Glomerular Capillary Endotheliosis 
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 56, Issue 3, Pages (September 1999)
Volume 72, Issue 12, Pages (December 2007)
Volume 72, Issue 3, Pages (August 2007)
Volume 81, Issue 5, Pages (March 2012)
Pre-eclampsia/Eclampsia
An unusual cause of acute renal failure
Volume 66, Issue 1, Pages (July 2004)
Mitochondrial dysfunction in focal segmental glomerulosclerosis of puromycin aminonucleoside nephrosis  M. Hagiwara, K. Yamagata, R.A. Capaldi, A. Koyama 
Hypertension, race, and glomeruli: more than simply a numbers game
C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 74, Issue 1, Pages (July 2008)
Volume 64, Issue 3, Pages (September 2003)
Volume 63, Issue 5, Pages (May 2003)
Volume 69, Issue 11, Pages (June 2006)
Fabry disease: An underrecognized cause of proteinuria
Volume 71, Issue 7, Pages (April 2007)
Volume 71, Issue 4, Pages (February 2007)
New drug toxicities in the onco-nephrology world
Volume 70, Issue 3, Pages (August 2006)
H. Raffi, J.M. Bates, Z. Laszik, S. Kumar  Kidney International 
Endothelin antagonists in renal disease
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Ian M. Wu, Ethan P. Marin, Michael Kashgarian, Ursula C. Brewster 
Volume 57, Issue 4, Pages (April 2000)
Volume 71, Issue 9, Pages (May 2007)
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 69, Issue 11, Pages (June 2006)
Accepting prospective kidney donors with asymptomatic urinary abnormalities: Are we shooting in the dark?  N. Vadivel, A. Stankovic, H.G. Rennke, A.K.
Volume 56, Issue 6, Pages (December 1999)
Thrombotic microangiopathy after hematopoietic cell transplantation.
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Tissue proteomics: a new investigative tool for renal biopsy analysis
Presentation transcript:

Volume 71, Issue 10, Pages 977-984 (May 2007) Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1  A. Makris, C. Thornton, J. Thompson, S. Thomson, R. Martin, R. Ogle, R. Waugh, P. McKenzie, P. Kirwan, A. Hennessy  Kidney International  Volume 71, Issue 10, Pages 977-984 (May 2007) DOI: 10.1038/sj.ki.5002175 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Increase in Rest and Sleep SBP and DBP after UPI. The change in intra-arterial BP at rest and sleep compared with baseline was monitored by implanted telemeters in pregnant baboons undergoing either selective unilateral uterine artery ligation (UPI, n=3, circles) or sham procedure (Sham, n=2, squares). (a) Rest SBP change, (b) Rest DBP change, (c) Sleep SBP, (d) Sleep DBP. #Indicates a significant difference between the UPI and Sham groups at the designated time point. *Indicates a significant difference between the marked data point and baseline. mm Hg – millimeters of mercury, mean±s.e.m. displayed, significance set at P<0.05. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Urinary protein and albumin excretion increases after UPI. The excretion of urinary protein and albumin in pregnant baboons that underwent UPI (UPI, n=3, circles) and those that underwent a sham procedure (Sham, n=2, squares). Clinically significant human protein excretion is 30mg/mmol (265mg/g) (marked by dotted horizontal line). (a) Urinary protein excretion. (b) Urinary albumin excretion. #Indicates a significant difference between the UPI and Sham groups at the designated time point. *Indicates a significant difference between the marked data point and baseline. Mean±s.e.m. displayed, significance set at P<0.05. To convert from mg/mmol to mg/g, multiply by 8.84. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Renal light microscopy changes identical to human preeclampsia. Light microscopy changes in the baboon after 14 days of UPI were consistent with human renal changes in preeclampsia (hematoxylin and eosin). Compared with the normal baseline renal histology (a), after the induction of UPI renal biopsy demonstrated (b) expansion of the mesangium (arrow), endothelial cell swelling (arrow head), and reduction in capillary lumen were noted. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 4 Renal electron microscopy changes identical to human preeclampsia. Electron microscopy (a–d) demonstrated more marked renal changes consistent with human preeclampsia than light microscopy. Demonstrated is marked endotheliosis (a) with some capillaries (cap) showing loss of endothelial cells and others showing widening of the subendothelial space (white arrow), which contains hyaline material (b). There was also evidence of mesangial expansion (c, mes) and fibrin (f) and fibrinoid (fd) material within the mesangium (d). It is important to note that in some areas the podocyte foot processes (a and c, pp) are well preserved for the degree of endotheliosis and proteinuria. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 5 Plasma sFLT-1increases after the induction of UPI. #Indicates a significant difference between the UPI (n=3) and Sham (n=2) groups at the indicated time point. *Indicates a significant difference between the marked data point and baseline. Mean±s.e.m displayed, significance set at P<0.05. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 6 Increase in placental and PBMC sFLT-1 mRNA expression after the induction of UPI. Using quantitative polymerase chain reaction, sFLT-1 expression was assessed in serially obtained placental (a) and PBMC (b) samples. #Indicates a significant difference between the UPI (n=3) and Sham (n=2) groups. Mean±s.e.m displayed, significance set at P<0.05. Kidney International 2007 71, 977-984DOI: (10.1038/sj.ki.5002175) Copyright © 2007 International Society of Nephrology Terms and Conditions